Dialysis provider Fresenius Medical Care AG & Co. KGaA is teaming with the diabetes research and education organization Joslin Diabetes Center Inc. to develop renal care programs in some Joslin Affiliated Centers for patients with diabetic kidney disease.

Fresenius Medical Care and Joslin will develop clinical guidelines and care delivery systems to manage high blood pressure, glucose, and nutrition in patients with diabetic kidney disease, according to a news release. In addition, the organizations will help educate patients as they prepare for the possibility of end-stage renal disease and the need for dialysis or kidney transplantation. The organizations said they will seek to improve patient outcomes while reducing unnecessary or lengthy hospitalizations, drug interactions and overall morbidity and mortality associated with uncoordinated care.

Read also: ASN president urges Congress to create federal prize competition to boost innovative kidney research

“Identifying and treating individuals with chronic kidney disease, especially those with diabetes, as early as possible can help us improve health outcomes for patients and lower costs for the health care system,” said Ron Kuerbitz, chief executive officer of Fresenius Medical Care North America. “But even more exciting is what this research can mean for the future. We hope that bringing together the world leaders in diabetes research and kidney care will lay the foundation for future therapeutic breakthroughs.”